Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Immune Deficiencies”

686 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 686 results

Testing effectiveness (Phase 2)Looking for participantsNCT03266627
What this trial is testing

Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection

Who this might be right for
AdenovirusPrimary Immune Deficiency Disorder
New York Medical College 20
Early research (Phase 1)Study completedNCT02218294
What this trial is testing

Study to Determine How BCX4161 is Metabolized and Eliminated by the Body

Who this might be right for
Hereditary Angioedema
BioCryst Pharmaceuticals 7
Not applicableUnknownNCT03198195
What this trial is testing

Post-transplant Cyclophosphamide in Wiskott-Aldrich Syndrome

Who this might be right for
Wiskott-Aldrich Syndrome
Capital Research Institute of Pediatrics 5
Testing effectiveness (Phase 2)UnknownNCT03252600
What this trial is testing

Lenalidomide, Dexamethasone, and Elotuzumab With or Without Cyclophosphamide in Treating Patients With Relapsed Primary Amyloidosis

Who this might be right for
Recurrent Primary Amyloidosis
Barbara Ann Karmanos Cancer Institute 53
Not applicableAvailableNCT06731036
What this trial is testing

Expanded Access to CD34+ Selection Utilizing Miltenyi CliniMACS Prodigy® for Patients Receiving Peripheral Blood Stem Cell Transplantations and Stem Cell Boosts

Who this might be right for
Severe Combined ImmunodeficiencyFanconi AnemiaDyskeratosis Congenita+1 more
University of Florida
Large-scale testing (Phase 3)Study completedNCT01458171
What this trial is testing

Follow-up Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (Japan Study)

Who this might be right for
Primary Immune Deficiency Disorder
CSL Behring 23
Large-scale testing (Phase 3)Study completedNCT02327351
What this trial is testing

TCR Alpha/Beta Depletion for HSCT From Haploidentical and Unrelated Donors in the Treatment of PID

Who this might be right for
Primary Immune Deficiency DisorderHematopoietic Stem Cell Transplantation
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 98
Not applicableUnknownNCT01646411
What this trial is testing

300 Antibody Diagnostic Test Kit

Who this might be right for
Acute Bacterial InfectionsAcute Viral Infections
The Plasma Source 300
Large-scale testing (Phase 3)Study completedNCT02810444
What this trial is testing

Study to Investigate Efficacy, Safety and Pharmacokinetics of BT595 in Subjects With PID

Who this might be right for
Primary Immunodeficiency Disease
Biotest 81
Not applicableStudy completedNCT03716700
What this trial is testing

Real-world CANadian CUvitru Non-Interventional Study in Subjects Transitioning From Subcutaneous Immunoglobulin (CANCUN)

Who this might be right for
Primary Immunodeficiency Diseases (PID)
Baxalta now part of Shire 126
Large-scale testing (Phase 3)Study completedNCT01188564
What this trial is testing

Efficacy, Safety and Immunogenicity Study of Recombinant Human C1 Inhibitor for the Treatment of Acute HAE Attacks

Who this might be right for
Hereditary Angioedema
Pharming Technologies B.V. 75
Not applicableStudy completedNCT02116764
What this trial is testing

Analysis of Patients Treated for Chronic Granulomatous Disease Since January 1, 1995

Who this might be right for
Chronic Granulomatous Disease
National Institute of Allergy and Infectious Diseases (NIAID) 137
Large-scale testing (Phase 3)Study completedNCT06467084
What this trial is testing

Open-Label Safety, PK, and Efficacy Trial of Sebetralstat (KVD900) in Pediatric Patients (Ages 2-11) With HAE Type I or II

Who this might be right for
Hereditary Angioedema
KalVista Pharmaceuticals, Ltd. 36
Large-scale testing (Phase 3)Study completedNCT03939533
What this trial is testing

Study to Monitor Subcutaneous Human Immunoglobulin Administered at Modified Dosing Regimens in Patients With Primary Immunodeficiency Diseases

Who this might be right for
Primary Immune Deficiency Disorder
Octapharma 64
Early research (Phase 1)Study completedNCT03202784
What this trial is testing

A Relative Bioavailability Study of Two Formulations of BCX7353

Who this might be right for
Hereditary Angioedema
BioCryst Pharmaceuticals 24
Testing effectiveness (Phase 2)Study completedNCT00851409
What this trial is testing

The Safety and Immunogenicity of Repeated rhC1INH Administration

Who this might be right for
Genetic DisordersHereditary Angioedema
Pharming Technologies B.V. 25
Large-scale testing (Phase 3)Study completedNCT00912093
What this trial is testing

Icatibant in Patients With Acute Attacks of Hereditary Angioedema (FAST-3)

Who this might be right for
Hereditary Angioedema
Shire 98
Testing effectiveness (Phase 2)Enrolling By InvitationNCT01852370
What this trial is testing

Sequential Cadaveric Lung and Bone Marrow Transplant for Immune Deficiency Diseases

Who this might be right for
Severe Combined Immunodeficiency (SCID)Immunodeficiency With Predominant T-cell Defect, UnspecifiedSevere Chronic Neutropenia+6 more
Paul Szabolcs 16
Not applicableNot Yet RecruitingNCT07516002
What this trial is testing

Immunoglobulin Efficacy and Immune Profiling in Antibody Immunodeficiency

Who this might be right for
Primary Immunodeficiency Diseases
Peking University People's Hospital 15
Early research (Phase 1)Ended earlyNCT00030381
What this trial is testing

Iododoxorubicin in Treating Patients With Primary Systemic Amyloidosis

Who this might be right for
Primary Systemic Amyloidosis
National Cancer Institute (NCI) 22
Next Page